Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Catalyst CPRX Stock Risk Analysis Investor Interest 20260416 Ingredion Incorporated INGR Stock Analysis Buy or Sell Technical Weakness 20260415 Halozyme Therapeutics HALO Stock Growth Potential Investors Pile In 20260418 HBM Hudbay posts 94 yearoveryear Q4 2025 revenue growth misses EPS estimates sharply stock dips slightly BKU BankUnited reports 145 Q1 2026 EPS miss shares fall 239 on weak investor sentiment LLYVK Liberty posts nearly in line Q4 2025 EPS results shares edge higher on stable investor sentiment Why Post Holdings POST financial health is stronger than most think Momentum Fading 20260511 Q1 GDP Advance Estimate Comes in at 20 Falling Short of Market Expectations Genenta GNTA Down 317 How Low Could It Go 20260515 Golds SafeHaven Appeal Wanes as Rising Real Yields Weigh on Investors Franklin Wireless Earnings Miss Estimates by 012 Revenue Also Below Forecasts Cartesian Therapeutics RNAC Drops 733 Key Support at 607 20260519 Mesa Laboratories MLAB Slides 142 as Selling Pressure Mounts 20260519 Gold Rally May Depend on Renewed Fed Rate Cut Expectations AI Wealth Must Benefit Public South Korea Deputy PM Warns Amid Samsung Labor Dispute Trainline Raises FullYear Guidance Again on Strong Demand IRS Settlement Halts Tax Audits on President Trump and Family Businesses Retail Sector Job Growth Surges Despite Consumer Caution Signals CPF LIFE vs SelfInvesting The Critical Factor of Financial Management in Retirement BJRI Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher SGLY Q3 2019 Earnings Significant EPS Miss Amid Undisclosed Revenue Figures PTLO Q1 2026 Earnings EPS Miss of 001 Highlights Ongoing Operational Challenges QH Q4 2021 Earnings Massive EPS Miss Highlights Operational Challenges ILPT Q1 2026 Earnings NarrowerthanExpected Loss as Surplus of 3137 Beats Street Estimates Garrett Motion Q1 2026 Earnings EPS Surges Past Estimates Amidst Limited Revenue Disclosure Real Asset Acquisition Corp RAAQ Slips 282 as Price Approaches Key Support Energy Focus EFOI Inches Higher Testing Key Resistance Near 409 Iterum Therapeutics ITRM Holds at 003 as MicroCap Biotech Waits for Catalysts Waldencast plc WALD Shows Resilience with 382 Gain Testing Key Resistance OrthoPediatrics Corp KIDS Holds Steady Near Resistance Eyes Breakout Potential